Home » Stocks » PFE

Pfizer Inc. (PFE)

Stock Price: $33.71 USD -0.05 (-0.13%)
Updated Feb 25, 2021 1:50 PM EST - Market open
Market Cap 187.60B
Revenue (ttm) 48.65B
Net Income (ttm) 8.69B
Shares Out 5.56B
EPS (ttm) 1.71
PE Ratio 19.75
Forward PE 10.94
Dividend $1.52
Dividend Yield 4.51%
Trading Day February 25
Last Price $33.71
Previous Close $33.75
Change ($) -0.05
Change (%) -0.13%
Day's Open 33.75
Day's Range 33.59 - 34.11
Day's Volume 20,219,213
52-Week Range 26.77 - 42.62

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
CNBC - 1 hour ago

Pfizer is exploring two paths with its vaccine to try providing more protection against new Covid strains, according to board member Dr. Scott Gottlieb.

InvestorPlace - 3 hours ago

These 5 stocks are great stocks to buy in any future market crash, as they all have good fundamentals and great long-term prospects. The post 5 Surefire Stocks If the Market Crashes appeared f...

Other stocks mentioned: AAPL, JNJ, KO, WMT
CNBC Television - 3 hours ago

Pfizer board member Scott Gottlieb on variant-specific Covid vaccine

Pfizer and BioNTech said on Thursday they are testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus. Dr. Scott Gottlieb, mem...

Other stocks mentioned: BNTX
Proactive Investors - 4 hours ago

Moderna, Inc. (NASDAQ:MRNA) said it expects to make US$18.4bn (£13bn) in revenue this year as governments worldwide have booked millions of doses of its COVID-19 vaccine. In 2020, total revenu...

Other stocks mentioned: BNTX, MRNA
Proactive Investors - 6 hours ago

Moderna, Inc. (NASDAQ:MRNA) said it expects to make US$18.4bn (£13bn) in revenue this year as governments worldwide have booked millions of doses of its COVID-19 vaccine. In 2020, total revenu...

Other stocks mentioned: BNTX, MRNA
CNBC Television - 6 hours ago

Pfizer-BioNTech to study variant-specific booster for Covid vaccine

Pfizer and BioNTech said on Thursday they are testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus. CNBC's Meg Tirrell repo...

Other stocks mentioned: BNTX
Benzinga - 6 hours ago

A real-world study of the coronavirus vaccine developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) showed the drug to be 94 percent effective at preventing COVID-19. What Happen...

Other stocks mentioned: BNTX
Business Wire - 7 hours ago

NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today they have begun an evaluation of the safety and immunogenicity of a third dos...

Other stocks mentioned: BNTX
Business Wire - 1 day ago

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareh...

The Motley Fool - 1 day ago

The pharma giant is setting itself up for success, although a little luck also helps.

Benzinga - 1 day ago

The FDA has accepted  Pfizer Inc's (NYSE: PFE) marketing application seeking approval for TicoVac under priority review status. TicoVac is the tick-borne encephalitis (TBE) vaccine for active ...

Other stocks mentioned: BNTX
Benzinga - 1 day ago

Pfizer Inc. (NYSE: PFE), Moderna Inc. (Nasdaq: MRNA) and Johnson & Johnson (NYSE: JNJ) said they are committed to making a total of 240 million doses of COVID-19 vaccines available in the U.S....

Other stocks mentioned: BNTX, JNJ, MRNA
GuruFocus - 1 day ago

Even investors that don't own the stocks must have had their interest piqued about the goings-on with GameStop Corp. (NYSE:GME), AMC Entertainment Holdings Inc. (NYSE:AMC) and Express Inc. (NY...

Other stocks mentioned: AMC, EXPR, GME, JNJ, LLY, MRK
Business Wire - 1 day ago

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company's Biologics License Application (BLA...

Forbes - 1 day ago

Pfizer and Moderna said Tuesday they're making improvements that will allow them to deliver more vaccines in the coming months.

Other stocks mentioned: BNTX, MRNA
Forbes - 2 days ago

Last week, there were two positive developments relating to Pfizer and its German partner BioNTech's Covid-19 vaccine, and one possible negative development. Firstly, Pfizer says based on inte...

Other stocks mentioned: BNTX
Zacks Investment Research - 2 days ago

The FDA encourages companies to evaluate the impact of COVID-19 virus variants on the efficacy or performance of their COVID-19 vaccines, tests and medicines.

Other stocks mentioned: BNTX, JNJ, LLY, MRNA, REGN
The Motley Fool - 2 days ago

The good news keeps on coming.

Other stocks mentioned: BNTX
InvestorPlace - 2 days ago

When starting out, it's probably best to look at quality. Here are seven familiar names for new investors to consider.

Other stocks mentioned: BAC, DIS, FB, NKE, PEP, PG
Bloomberg Markets and Finance - 2 days ago

Pfizer-Biontech Shot Stops COVID-19 Spread, Israeli Study Shows

Feb.22 -- Sheba Medical Center Deputy Director General Arnon Afek speaks with Bloomberg's Alix Steel and Guy Johnson about the effectiveness of the Pfizer-Biontech vaccine on "Bloomberg Market...

Other stocks mentioned: BNTX
Forbes - 2 days ago

“We should be very encouraged by these initial findings,” said the head of Public Health England.

Other stocks mentioned: BNTX
GuruFocus - 3 days ago

Investing in dividend growth stocks is one of the most famous strategies today, but unfortunately, finding lucrative opportunities has become increasingly difficult as a result of the record b...

Business Wire - 3 days ago

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Pfizer Biopharmaceuticals...

Benzinga - 3 days ago

The Israel health ministry said that Pfizer Inc (NYSE: PFE) and BioNtech SE's (NASDAQ: BNTX) COVID-19 vaccine had proved 95.8% effective in preventing coronavirus infection among those vaccina...

Other stocks mentioned: BNTX
Benzinga - 3 days ago

The U.S. President Joe Biden met with Pfizer Inc's (NYSE: PFE) CEO Albert Bourla on Friday to discuss its COVID-19 vaccine stockpile estimated to be ready by Summer 2021, Bloomberg reports. Th...

The Motley Fool - 4 days ago

You should definitely follow Buffett in one way.

The Motley Fool - 4 days ago

Don't stress out over your stocks -- here are three that guarantee sweet dreams and healthy returns.

Other stocks mentioned: AMZN, JNJ, MRNA, TGT
Forbes - 4 days ago

That's good news for the rest of the world.

Other stocks mentioned: BNTX
The Motley Fool - 5 days ago

The new findings promise simpler transport, storage, and administration for BNT162b2.

Other stocks mentioned: BNTX
Forbes - 5 days ago

Pfizer CEO Albert Bourla said Friday there wasn't clear evidence yet on whether it would be safe to forgo a second dose of its coronavirus vaccine or delay administering it, a day after a stud...

Other stocks mentioned: BNTX
Benzinga - 5 days ago

On Tuesday, Feb. 16, the SEC released filings from many high-profile investors such as Warren Buffett, Cathie Wood and Michael Burry. Burry, of "The Big Short" fame, had GameStop as his bigges...

Other stocks mentioned: KHC
CNBC Television - 5 days ago

Pfizer: Vaccine can be stored for two weeks at freezer temperatures

CNBC's Meg Tirrell reports on the current state of Covid vaccines, including Pfizer's remarks on its vaccine storage requirements.

Other stocks mentioned: BNTX
Forbes - 6 days ago

Pfizer's numbers alone can be deceptive. That's why we took a deep dive into the company's trends and insights into its future.

Zacks Investment Research - 6 days ago

Pfizer (PFE) and BioNTech begin dosing in a mid-to-late-stage study on their COVID-19 vaccine in healthy pregnant women.

Other stocks mentioned: BNTX
TechCrunch - 6 days ago

The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than it debuted with. Originally, the mRNA-based vaccine had to be maintain...

Other stocks mentioned: BNTX
CNBC - 6 days ago

Pfizer is seeking permission from the FDA to store its vaccine for two weeks at temperatures commonly found in pharmaceutical freezers and refrigerators.

Other stocks mentioned: BNTX
The Motley Fool - 6 days ago

Although these stocks are down to start the year, don't count them out over the long term.

Other stocks mentioned: CPB, PEG
Forbes - 6 days ago

The researchers said the findings support policies delaying the second shot in efforts to stretch supplies and speed up immunizations.

Other stocks mentioned: BNTX
The Motley Fool - 6 days ago

This is highly unusual behavior from a historically passive investor -- but there is an explanation.

Other stocks mentioned: AXP, BAC, USB, WFC
Benzinga - 6 days ago

The first dose of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) vaccine could be highly efficacious against COVID-19, a study has found — fueling debate over delaying the second dose t...

Other stocks mentioned: BNTX
The Motley Fool - 6 days ago

The testing will also be extended to children.

Other stocks mentioned: BNTX
GuruFocus - 6 days ago

Prem Watsa (Trades, Portfolio), the founder and chairman of Fairfax Financial Ltd. (TSX:FFH), disclosed this week that his insurance company's top five trades during the fourth quarter feature...

Other stocks mentioned: FIT, GIL, MRK, NTES
InvestorPlace - 6 days ago

As Covid-19 becomes endemic, rich governments will turn to Novavax to vaccinate people in developing economies. NVAX stock will benefit.

Other stocks mentioned: AZN, BNTX, JNJ, NVAX
Zacks Investment Research - 1 week ago

Pfizer (PFE)/BioNTech (BNTX) win a deal for 200 million more doses of its COVID-19 vaccine in Europe.

Other stocks mentioned: BNTX
Benzinga - 1 week ago

A laboratory study suggests that a COVID-19 mutant strain prevalent in South Africa may lower antibody protection from the Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) vaccine and it ...

Other stocks mentioned: BNTX
Invezz - 1 week ago

Insiders at Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) and other COVID-19 vaccine makers collectively sold nearly half a billion dollars worth of their stock but one pro isn't alar...

Other stocks mentioned: MRNA
CNBC Television - 1 week ago

Pfizer: South African variant could significantly reduce vaccine protection

A new study shows the neutralization levels against the South African covid variant were two-thirds lower when compared to the older variants of the Covid-19. It's unclear what this would look...

Other stocks mentioned: BNTX
The Motley Fool - 1 week ago

These two pharma giants' recent struggles in the stock market represent a buying opportunity.

Other stocks mentioned: MRK
Reuters - 1 week ago

Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supplies it had...

Other stocks mentioned: BNTX
Business Wire - 1 week ago

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359) of elranatamab...

About PFE

Pfizer develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in vari... [Read more...]

Industry
Drug Manufacturers-General
Founded
1849
CEO
Albert Bourla
Country
United States
Stock Exchange
NYSE
Ticker Symbol
PFE
Full Company Profile

Financial Performance

In 2019, Pfizer's revenue was $51.75 billion, a decrease of -3.54% compared to the previous year's $53.65 billion. Earnings were $16.27 billion, an increase of 45.91%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for Pfizer stock is "Buy." The 12-month stock price forecast is 41.09, which is an increase of 21.91% from the latest price.

Price Target
$41.09
(21.91% upside)
Analyst Consensus: Buy